329 related articles for article (PubMed ID: 31689494)
1. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Mao L; Qi Z; Zhang L; Guo J; Si L
Front Immunol; 2021; 12():680407. PubMed ID: 34149718
[TBL] [Abstract][Full Text] [Related]
3. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Acral Lentiginous Melanoma.
Nakamura Y; Fujisawa Y
Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
[TBL] [Abstract][Full Text] [Related]
5. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
6. Acral melanoma: new insights into the immune and genomic landscape.
Carvalho LAD; Aguiar FC; Smalley KSM; Possik PA
Neoplasia; 2023 Dec; 46():100947. PubMed ID: 37913653
[TBL] [Abstract][Full Text] [Related]
7. [Acral lentiginous melanoma: the current state of the problem].
Myasnyankin MY; Gafton GI; Anisimov VV; Matsko DE; Imyanitov EN; Semiletova YV
Vopr Onkol; 2015; 61(4):563-70. PubMed ID: 26571823
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional study of acral melanoma awareness in a group of South African final phase medical students.
Eksteen JM; Visser WI; de Wet J; Lombard C; Zunza M; Tod B
Indian J Dermatol Venereol Leprol; 2022; 88(3):444. PubMed ID: 35389032
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy and Immunotherapy for Melanoma in Japan.
Namikawa K; Yamazaki N
Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
[TBL] [Abstract][Full Text] [Related]
10. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
11. Subungual melanoma: a deceptive disorder.
Patel GA; Ragi G; Krysicki J; Schwartz RA
Acta Dermatovenerol Croat; 2008; 16(4):236-42. PubMed ID: 19111151
[TBL] [Abstract][Full Text] [Related]
12. Acral Lentiginous Melanoma.
Goydos JS; Shoen SL
Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
[TBL] [Abstract][Full Text] [Related]
13. Melanoma of the Foot.
Bristow I; Bower C
Clin Podiatr Med Surg; 2016 Jul; 33(3):409-22. PubMed ID: 27215160
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy.
Gajón JA; Juarez-Flores A; De León Rodríguez SG; Aguilar Flores C; Mantilla A; Fuentes-Pananá EM; Bonifaz LC
Arch Med Res; 2022 Dec; 53(8):794-806. PubMed ID: 36460547
[TBL] [Abstract][Full Text] [Related]
15. Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
Li J; Smalley I; Chen Z; Wu JY; Phadke MS; Teer JK; Nguyen T; Karreth FA; Koomen JM; Sarnaik AA; Zager JS; Khushalani NI; Tarhini AA; Sondak VK; Rodriguez PC; Messina JL; Chen YA; Smalley KSM
Clin Cancer Res; 2022 May; 28(10):2131-2146. PubMed ID: 35247927
[TBL] [Abstract][Full Text] [Related]
16. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
Jung S; Johnson DB
Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
[TBL] [Abstract][Full Text] [Related]
17. Acral melanoma with satellitosis, disguised as a longstanding diabetic ulcer: a great mimicry.
Mansur AT; Demirci GT; Ozel O; Ozker E; Yıldız S
Int Wound J; 2016 Oct; 13(5):1006-8. PubMed ID: 26400657
[TBL] [Abstract][Full Text] [Related]
18. PTEN regulates IGF-1R-mediated therapy resistance in melanoma.
Wang J; Sinnberg T; Niessner H; Dölker R; Sauer B; Kempf WE; Meier F; Leslie N; Schittek B
Pigment Cell Melanoma Res; 2015 Sep; 28(5):572-89. PubMed ID: 26112748
[TBL] [Abstract][Full Text] [Related]
19. C-Jun drives melanoma progression in PTEN wild type melanoma cells.
Kappelmann-Fenzl M; Gebhard C; Matthies AO; Kuphal S; Rehli M; Bosserhoff AK
Cell Death Dis; 2019 Aug; 10(8):584. PubMed ID: 31378787
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapies in Melanoma: Translational Research at Its Finest.
Ho AW; Tsao H
J Invest Dermatol; 2015 Aug; 135(8):1929-1933. PubMed ID: 26174532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
